Clinical depression laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(2 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no diagnostic laboratory findings associated with [[major depressive disorder]]. | |||
==Laboratory Findings== | ==Laboratory Findings== |
Latest revision as of 14:12, 7 May 2021
Clinical Depression Microchapters |
Diagnosis |
---|
Treatment |
Follow-up |
Case Studies |
Clinical depression laboratory findings On the Web |
American Roentgen Ray Society Images of Clinical depression laboratory findings |
Risk calculators and risk factors for Clinical depression laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no diagnostic laboratory findings associated with major depressive disorder.
Laboratory Findings
- There are no diagnostic laboratory findings associated with major depressive disorder.
- Dexamethasone suppression test:
- About 50% of patients with major depressive disorder have abnormal dexamethasone suppression test. Nonsuppression (positive test result) shows cortisol hypersecretion secondary to a hyperactive hypothalamus-pituitary-adrenal axis.
- However, dexamethasone suppression test is not routinely used in the diagnosis of major depressive disorders due to high rates of false positives and false negatives.
- Diminished TSH in response to TRH and decreased prolactin release in response to tryptophan have been reported in patients with major depression. However, the results are not definitive, and thus, are not used routinely used in clinical practice.